Search - tctmd.com

Displaying 201 - 220 of 979

Sort: Relevancy | Date

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Presenter: Sanjiv J. Shah

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Presenter: Joseph Maenza

March 04, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Presenter: Marat Fudim

March 04, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon E. Litwin

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

Presentation CTO 2024

Risk Stratification by Ejection Fraction Within a Cohort of Patients With CKD Undergoing Ultralow-Contrast IVUS Guided PCI

Presenter: Christopher Garnett

February 03, 2024

$Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction$

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Presenter: Jurij Avramovic

February 02, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Daily News

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Todd Neale

January 23, 2024

Advertisement

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Debating the Role of T-TEER in the Sickest Patients

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Risk Stratification by Ejection Fraction Within a Cohort of Patients With CKD Undergoing Ultralow-Contrast IVUS Guided PCI

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

GDMT Rates Low in HFrEF, Particularly in Women

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content